"Diagnosing Drug-Resistant Tuberculosis with the Xpert®MTB/RIF. The Risk for Rifampin Susceptible Cases"
written by Brenda Zaragoza, Rafael Laniado-Laborín,
published by Journal of Tuberculosis Research, Vol.5 No.3, 2017
has been cited by the following article(s):